Isleworth Healthcare Acquisition Corporation (ISLE)
$10.01
$0.00 (0.00%)As on 02-Sep-2022 09:30EDT
Market cap
$262 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
24.4
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$11 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-191.3
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$3.2
-
Face value
--
-
Shares outstanding
26,191,200
9 Years Aggregate
CFO
$346.39 Mln
EBITDA
$401.10 Mln
Net Profit
$-71.46 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Isleworth Healthcare Acquisition (ISLE)
| 1.7 | 0.3 | 0.8 | 2.4 | -- | -- | -- |
|
BSE Sensex*
| -10.8 | -0.6 | -1.7 | -8.5 | 6.4 | 7.6 | 11.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Isleworth Healthcare Acquisition (ISLE)
|
10.0 | 262.2 | 0.0 | 16.2 | -- | -- | 24.4 | 1.3 |
| 10.1 | 492.7 | 0.0 | 33.1 | -- | -- | 43.7 | 1.6 | |
| 10.0 | 518.5 | 0.0 | 6,948,327.1 | -- | -- | 23.3 | 1.3 | |
| 10.0 | 719.5 | 0.0 | 44.8 | -- | -- | 41.7 | 1.3 | |
| 10.1 | 255.8 | 0.0 | 118.7 | -- | -- | -- | 0.0 | |
| 5.1 | 28.3 | 5.8 | -0.2 | -103.6 | -- | 84.7 | 3.9 |
Shareholding Pattern
View DetailsAbout Isleworth Healthcare Acquisition (ISLE)
Isleworth Healthcare Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more... businesses. It intends to acquire a business in the biopharmaceutical or medical technology/device industries. The company was incorporated in 2020 and is based in Saint Petersburg, Florida. Read more
-
CEO & Director
Mr. Robert S. Whitehead
-
CEO & Director
Mr. Robert S. Whitehead
-
Headquarters
Saint Petersburg, FL
-
Website
FAQs for Isleworth Healthcare Acquisition (ISLE)
What is the current share price of Isleworth Healthcare Acquisition Corporation (ISLE) Today?
The share price of Isleworth Healthcare Acquisition Corporation (ISLE) is $10.01 (NASDAQ) as of 02-Sep-2022 09:30 EDT. Isleworth Healthcare Acquisition Corporation (ISLE) has given a return of 2.35% in the last 1 years.
What is the current PB & PE ratio of Isleworth Healthcare Acquisition Corporation (ISLE)?
The P/E ratio of Isleworth Healthcare Acquisition Corporation (ISLE) is 24.41 times as on 02-Sep-2022.
The P/B ratio of Isleworth Healthcare Acquisition Corporation (ISLE) is 1.27 times as on 02-Sep-2022, a 6 discount to its peers’ median range of 1.35 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
10.16
|
-6,454.15
|
|
2020
|
--
|
--
|
|
2015
|
--
|
--
|
|
2014
|
--
|
--
|
|
2013
|
--
|
--
|
What is the 52 Week High and Low of Isleworth Healthcare Acquisition Corporation (ISLE)?
The 52-week high and low of Isleworth Healthcare Acquisition Corporation (ISLE) are Rs -- and Rs -- as of 14-Jun-2026.
What is the market cap of Isleworth Healthcare Acquisition Corporation (ISLE)?
Isleworth Healthcare Acquisition Corporation (ISLE) has a market capitalisation of $ 262 Mln as on 02-Sep-2022. As per SEBI classification, it is a Small Cap company.
Should I invest in Isleworth Healthcare Acquisition Corporation (ISLE)?
Before investing in Isleworth Healthcare Acquisition Corporation (ISLE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.